Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
59 results about "Glucose Metabolism Disorder" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A metabolic disorder characterized by abnormal blood glucose levels.
Ether compounds
InactiveUS6459003B1Reduce contentLower cholesterol levelsNervous disorderAntipyreticDyslipidemiaCholesterol
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
InactiveUS6673780B2Antibacterial agentsBiocideDyslipidemiaPeroxisome proliferator-activated receptor
Owner:ESPERION THERAPEUTICS
Ketone compounds and compositions for cholesterol management and related uses
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Compositions and methods for treatment for glucose metabolism disorders
InactiveUS6852760B1Desired levelReduce severityBiocideHeavy metal active ingredientsMedicineGlucose polymers
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Owner:AKESIS PHARMA
Ether compounds and compositions for cholesterol management and related uses
InactiveUS6713507B2Reduce contentLower cholesterol levelsAntibacterial agentsBiocideDyslipidemiaPeroxisome proliferator-activated receptor
Owner:ESPERION THERAPEUTICS
Dihydroxyl compounds and compositions for cholesterol management and related uses
Owner:ESPERION THERAPEUTICS
Method and composition for the treatment of lipid and glucose metabolism disorders
InactiveUS20020187985A1Improved modification and regulationImprovement of one or more metabolic indicesBiocideAnimal repellantsBlood plasmaPlasma insulin
Disclosed are methods for modifying or regulating at least one of glucose or lipid metabolism disorders which comprises administering to a human or vertebrate subject a D1 dopamine agonist in conjunction with a dopamine D2 agonist where the conjoined administration is effective to improve at least one of the following lipid and glucose metabolic indices: body weight, body fat, plasma insulin, plasma glucose and plasma lipid, and plasma lipoprotein. In preferred embodiments, the administration of the D1 dopamine agonist and the D2 dopamine agonist is conducted at a predetermined time.
Owner:VEROSCI
Method and composition for the treatment of lipid and glucose metabolism disorders
InactiveUS20010016582A1Improved modification and regulationImprovement of one or more metabolic indicesBiocideCarbohydrate active ingredientsBlood plasmaPlasma insulin
Disclosed are methods for modifying or regulating at least one of glucose or lipid metabolism disorders which comprises administering to a human or vertebrate subject a D1 dopamine agonist in conjunction with a dopamine D2 agonist where the conjoined administration is effective to improve at least one of the following lipid and glucose metabolic indices: body weight, body fat, plasma insulin, plasma glucose and plasma lipid, and plasma lipoprotein. In preferred embodiments, the administration of the D1 dopamine agonist and the D2 dopamine agonist is conducted at a predetermined time.
Owner:CINCOTTA ANTHONY H
Ketone compounds and compositions for cholesterol management and related uses
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
InactiveUS20050233946A1Improve the level ofBlood glucose level is suppressedOrganic active ingredientsBiocideD-GlucoseGlucose polymers
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Owner:FINE STUART A +1
Ketone compounds and compositions for cholesterol management and related uses
ActiveUS20070155704A1Reduce contentLower cholesterol levelsAntibacterial agentsBiocideDyslipidemiaKetone
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Ketone compounds and compositions for cholesterol management and related uses
InactiveUS20040198814A1Increase weightReduce content of meatBiocideOrganic compound preparationDyslipidemiaKetone
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
The present invention relates to novel sulfoxide and bis-sulfoxide compounds, compositions comprising sulfoxide and bis-sulfoxide compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Ketone compounds and compositions for cholesterol management and related uses
ActiveUS7705177B2Reduce contentLower cholesterol levelsAntibacterial agentsBiocideDyslipidemiaKetone
Owner:ESPERION THERAPEUTICS
Compositions and methods of use for treating metabolic disorders
ActiveUS9920118B2Peptide/protein ingredientsAntibody mimetics/scaffoldsBody weightMetabolism disorder
A complex comprising a GDF15 polypeptide is described. Methods of treating individuals with a metabolism disorder, such as, glucose metabolism disorder and / or a body weight disorder, and compositions associated therewith, are provided.
Owner:NGM BIOPHARMLS
Compositions and methods of use for treating metabolic disorders
Owner:NGM BIOPHARMLS
Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
InactiveUS20050187144A1Desired levelImprove the level ofHeavy metal active ingredientsBiocideD-GlucoseGlucose polymers
Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
Owner:FINE STUART A +1
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
InactiveUS20050020694A1Increase weightImprove the level ofBiocideOrganic chemistryDysproteinemiasDisease cause
The invention encompasses novel sulfide and disulfide compounds, compositions comprising sulfide and disulfide compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
InactiveUS20040204502A1Reduce contentIncrease productionBiocideOrganic chemistryDyslipidemiaPeroxisome proliferator-activated receptor
The present invention relates to novel sulfoxide and bis-sulfoxide compounds, compositions comprising sulfoxide and bis-sulfoxide compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Ketone compounds and compositions for cholesterol management and related uses
InactiveUS20070149615A9Reduce contentLower cholesterol levelsBiocideOrganic compound preparationKetoneDysproteinemias
Owner:ESPERION THERAPEUTICS
Mimics of acyl coenzyme-A comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
InactiveUS20030236213A1Increase level of HDL cholesterolDecrease level of LDL-cholesterolAntibacterial agentsOrganic active ingredientsDyslipidemiaKetone
The invention relates to novel Acyl coenzyme-A mimics, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The Acyl coenzyme-A mimics, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, bacterial infection and impotence. In certain embodiments, the Acyl coenzyme-A mimics, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Formula goat milk powder with effects of improving sleep quality and enhancing immunity, and preparation method thereof
The invention discloses formula goat milk powder composed of dairy products, prebiotics, linseed oil, compound vitamins, compound minerals, phytosterol, taurine, phospholipids, spina date seeds, lilybulbs, longan flesh, ginseng, donkey-hide gelatin and black sesame seeds. The formula goat milk powder has the effects of tranquilizing the mind, calming the nerves, tonnfying and nourishing the blood, benefiting Qi, strengthening the spleen, benefiting intelligence, calming the nerves, reducing blood lipid, lowering blood pressure, enhancing immunity, resisting fatigue and so on; and thus, the formula goat milk powder is mainly suitable for the symptoms of insomnia, dreaminess, heart-blood deficiency, body weakness, debilitation, poor appetite, hyperlipidemia, glucose metabolism disorder andthe like caused by working overtime, staying up late, irregular eating and sleeping and so on. Being frequently taken, the formula goat milk powder is capable of effectively improving sleep quality, reducing blood lipid and lowering blood pressure as an auxiliary, preventing cardiovascular and cerebrovascular diseases, improving memory, enhancing immunity, resisting fatigue and so on.
Owner:GUANGZHOU HAOXIAOXIN MEDICAL EQUIP
Copper regulation evaluation and therapy
InactiveUS20110136157A1Improve the level ofMicrobiological testing/measurementMaterial analysis by optical meansDiseaseNeurological disorder
Assays methods for clinical evaluation of conditions that might be treated with copper antagonists. These conditions include diabetes and other glucose metabolism disorders, lipid disorders, neurological disorders, and heart disease. The assays utilize a correlation between copper levels and one or more of the markers hemoglobin AIc and extracellular superoxide dismutase activity, in order to detect the condition, predict progression of the condition and assess a patient's response to copper antagonist therapy in these conditions by monitoring the level of these markers.
Owner:PHILERA NEW ZEALAND
Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses
InactiveUS20030236212A1Increase level of HDL cholesterolInhibit synthesisAntibacterial agentsOrganic active ingredientsDyslipidemiaAcyl coenzyme A
The invention relates to novel Acyl coenzyme-A mimics, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising a ketone compound. The Acyl coenzyme-A mimics, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, bacterial infection and impotence. In certain embodiments, the Acyl coenzyme-A mimics, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver
InactiveCN103230486ASoothing the liver and invigorating the spleenWith promoting blood circulation and removing blood stasisDigestive systemPlant ingredientsFatty liverLiver tissue
The invention provides a traditional Chinese medicine composition, a preparation method thereof, and an application thereof in preparing medicines used for treating fatty liver. The traditional Chinese medicine composition provided by the invention has the functions of liver soothing, spleen invigorating, blood circulation activating, stasis removing, digestion promoting, and lipid reducing. The composition adopts an extract preparation process, and is also suitable for glucose metabolism disorder patients. As a result of preliminary clinical researches, the traditional Chinese medicine composition can be used for treating fatty liver with various causes. With the medicine composition, clinical symptoms, biochemical parameters and liver tissue changes of fatty liver patients can be ameliorated with different degrees.
Owner:苏州深久医药生物技术有限公司
Combinations of Vanadium with Antidiabetics for Glucose Metabolism Disorders
InactiveUS20080181970A1Improve the level ofBlood glucose level is suppressedBiocideHeavy metal active ingredientsGlucose polymersD-Glucose
Owner:AKESIS PHARMA
Ether compounds and compositions for cholesterol management and related uses
InactiveUS20040192771A1Increase productionEasy to transportBiocideOrganic chemistryDyslipidemiaPeroxisome proliferator-activated receptor
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
Owner:ESPERION THERAPEUTICS
Methods of treating glucose metabolism disorders
ActiveUS8609612B2Promote secretionLower Level RequirementsBiocidePeptide/protein ingredientsGlucose polymersD-Glucose
Owner:NGM BIOPHARMLS
Dietotherapy product for reducing hyperlipidemia and hyperglycemia
InactiveCN109043504AInexpensive componentsCan adjust and improve diet structureFood ingredient functionsAcute hyperglycaemiaVitamin C
The invention provides a dietotherapy product for reducing hyperlipidemia and hyperglycemia. The dietotherapy product is prepared from the following raw material components in parts by weight: 17 to 45 parts of oat, 5 to 40 parts of black soybean, 5 to 30 parts of soybean, 5 to 20 parts of devilstongue, 2 to 5 parts of lotus leaf, 3 to 10 parts of buckwheat, 2 to 3 parts of fructus jujubae, 2 to 3parts of fructus crataegi, 5 to 10 parts of rhizoma dioscoreae, 0.02 to 1 part of vitamin C, 0 to 0.05 part of vitamin E, 1.5 to 5 parts of linolenic acid, 0.005 to 0.01 part of zinc and 0.01 to 0.03part of anthocyanin. The dietotherapy product provided by the invention is prepared by specific raw materials according to a specific dosage relationship; synergistic interaction between various rawmaterial components are fully played, so that the aim of synergistic effect is achieved; the effects of lowering blood pressure, blood fat and blood sugar are greatly improved, fat metabolism or transfer abnormalities and glucose metabolism disorder are avoided, and further the balance of lipid metabolism and blood vessel dredging are achieved.
Owner:重庆璞生健康科技有限公司
Methods of Treating Glucose Metabolism Disorders
InactiveUS20140099295A1Promote secretionLower Level RequirementsHydrolasesPeptide/protein ingredientsLevel insulinMuscle functions
Compositions and methods for modulating levels of PLA2G12A are provided. Methods for treating various conditions, such as conditions that are associated with or that result in reduced muscle function and / or muscle mass, are provided. Methods for modulating glucose and / or insulin levels in glucose metabolism disorders are provided.
Owner:NGM BIOPHARMLS
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com